Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03322930 · ClinicalTrials.gov registry record
Rod Sensitivity in Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP)
A clinical trial, sponsored by Retina Foundation of the Southwest.
- Completed
- Registry status
- 40
- Enrollment target
NCT03322930: Completed study, sponsored by Retina Foundation of the Southwest.
NCT03322930 is a clinical trial that has completed, run by Retina Foundation of the Southwest. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03322930 has completed, sponsored by Retina Foundation of the Southwest.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
A new fundus-guided microperimeter (MP-3S) has been developed by Nidek, Inc. to track the fundus of the patient and present stimuli in specific anatomically-defined locations. Furthermore, this tracking means that exactly the same locations can be tested on subsequent (follow-up) visits. The investigators will use a method called two-color perimetry to map rod and cone sensitivity on this device. With this technique, the sensitivity difference (blue-red) to chromatic test stimuli can be used to determine whether rods, cones or both photoreceptor systems mediate the threshold at a given location in the macula.
Primary Outcome
Number of participants with rod sensitivity measured in decibels at multiple retinal locations within the central retina
Interventions
- DIAGNOSTIC_TEST Rod sensitivity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2017-10-01 |
| Est. Completion | 2019-03-01 |
What the finished NCT03322930 record still lists
NCT03322930 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Rod sensitivity is the first listed.
NCT03322930 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03322930 about?
NCT03322930 is a clinical study titled "Rod Sensitivity in Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP)". A new fundus-guided microperimeter (MP-3S) has been developed by Nidek, Inc. to track the fundus of the patient and present stimuli in specific anatomically-defined locations. Furthermore, this tracking means that exactly the same locations can be tested on subsequent (follow-up) visits. The investi...
What is the current status of trial NCT03322930?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2017-10-01. Estimated completion is 2019-03-01.
What interventions are being tested in trial NCT03322930?
The interventions under investigation include: Rod sensitivity (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03322930?
This trial is sponsored by Retina Foundation of the Southwest, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI